NYSE: $GSK A New Option for Challenging Infections The landscape of antibiotic treatment has evolved with the recent FDA approval of UTEBZI (tebipenem pivoxil hydrobromide). This medication marks a significant advancement as the first oral carbapenem antibiotic approved for the treatment of complicated urinary tract infections (cUTIs) in adults. Understanding UTEBZI UTIs can often be…